A randomized clinical trial of a dietary intervention and mental health associations in adults with increased genetic risk for obesity
Abstract
Nutrigenetic parameters influence quality of life (QoL) by highlighting how genetic variations affect weight management and allow for personalized dietary recommendations that enhance health status. The present study investigates the effect of a dietary intervention on the SF-12 physical (SF-PCS-12) and mental components (SF-MCS-12) of adults with overweight and obesity, at high genetic risk for increased Body Mass Index (BMI). Data from 80 participants were analyzed, all of whom were randomized at baseline to follow either a high-protein or high-carbohydrate hypocaloric diet for three months. QoL was measured using the SF-12 questionnaire, with self-reported assessments conducted at baseline and at the end of each intervention month. Differences pre- and post- intervention were assessed using the Wilcoxon signed-rank test. Additionally, 10 BMI-related variants were investigated for potential effects on the observed differences in SF-PCS-12 and SF-MCS-12, via linear regressions using the Plink software. Overall, no statistically significant differences were observed in SF-PCS-12 and SF-MCS-12 scores post-intervention. However, while SF-PCS-12 showed less improvement in high-risk individuals, participants with high-BMI risk alleles demonstrated a notable increase in SF-MCS-12 scores. This finding suggests that dietary interventions may positively impact mental health, even in individuals with a heightened genetic risk for obesity.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 80 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.